SEOM-GEICO clinical guidelines on endometrial cancer (2021)
Clin. transl. oncol. (Print)
; 24(4): 625-634, abril 2022. tab
Artigo
em Inglês
| IBECS
| ID: ibc-203766
Biblioteca responsável:
ES1.1
Localização: ES15.1 - BNCS
ABSTRACT
Endometrial cancer (EC) is the second most common gynecological malignancy worldwide, the first in developed countries [Sung et al. in CA Cancer J Clin 71209249, 2021]. Although a majority is diagnosed at an early stage with a low risk of relapse, an important proportion of patients will relapse. Better knowledge of molecular abnormalities is crucial to identify high-risk groups in early stages as well as for recurrent or metastatic disease for whom adjuvant treatment must be personalized. The objective of this guide is to summarize the current evidence for the diagnosis, treatment, and follow-up of EC, and to provide evidence-based recommendations for clinical practice.
Texto completo:
Disponível
Coleções:
Bases de dados nacionais
/
Espanha
Base de dados:
IBECS
Assunto principal:
Neoplasias do Endométrio
Limite:
Feminino
/
Humanos
Idioma:
Inglês
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2022
Tipo de documento:
Artigo
Instituição/País de afiliação:
Complejo Hospitalario de Toledo/Spain
/
Complexo Hospitalario Universitario de A Coruña/Spain
/
Fundación Instituto Valenciano de Oncología (IVO)/Spain
/
Hospital Clínic of Barcelona/Spain
/
Hospital Clínico Universitario of Valencia/Spain
/
Hospital Universitari Son Espases/Spain
/
Hospital Universitari i Politècnic La Fe/Spain
/
Hospital Universitario Reina Sofía/Spain
/
Infanta Sofía University Hospital/Spain
/
Institut Català dOncologia (ICO)/Spain